YDES Stock Analysis: Buy, Sell, or Hold?
YDES - YD Bio Limited Ordinary Shares
$6.12
0.20 (3.38%)
â˛
5d:
-3.32%
30d:
+91.85%
90d:
+169.6%
WAIT
LOW Confidence
Analysis Updated: Oct 19, 2026 12:00 AM ET
Get Alerted When YDES Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: YDES is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: YDES is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: YDES is currently trading at $6.12, which is considered fair relative to its 30-day fair value range of $3.84 to $7.15.
Technical Outlook: Technically, YDES is in a strong uptrend. Immediate support is located at $5.20, while resistance sits at $7.13. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: YDES scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, YDES is in a strong uptrend. Immediate support is located at $5.20, while resistance sits at $7.13. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: YDES scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.84 -
$7.15
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.84 -
$7.15
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.20
Resistance Level
$7.13
Current Trend
Strong Uptrend
Technical data as of
Oct 19, 2026
Fundamental Context
Revenue Growth (YoY)
314.9%
Profit Margin
24.7%
Share & Embed Analysis
Last updated: October 20, 2026 12:51 AM ET
Data refreshes hourly during market hours. Next update: 1:51 AM
Data refreshes hourly during market hours. Next update: 1:51 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is YDES showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$571 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
27 analysts |
$436 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$369 | 44 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 58 HOLD |
|
STOK
Stoke Therapeutics Inc |
STRONG BUY
14 analysts |
$46 | 74 BUY |